(2022) identified a distinct Treg phenotype that is increased in tumor tissue compared to patient-matched blood and defined by enriched expression of the TNF receptor superfamily member 1B (TNFR2) (30). The gene discussed is TNFRSF1B; the disease is neoplasm.